Purdue Pharma is the latest company to sign a screening for potential drug candidates with Norak Biosciences.
Terms of thed eal were not disclosed.

Purude will use Norak’s Transflour technology to assess its library of potential drug compounds.

The focus will be on so-called G protein-coupled receptors.

Norak: www.norakbio.com